Statin-induced Ras Activation Integrates the Phosphatidylinositol 3-Kinase Signal to Akt and MAPK for Bone Morphogenetic Protein-2 Expression in Osteoblast Differentiation

Nandini Ghosh‐Choudhury, Chandi C. Mandal, Goutam Ghosh Choudhury

Journal of Biological Chemistry · 2006 · 150 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

Lovastatin promotes osteoblast differentiation by increasing bone morphogenetic protein-2 (BMP-2) expression. We demonstrate that lovastatin stimulates tyrosine phosphorylation of the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), leading to an increase in its kinase activity in osteoblast cells. Inhibition of PI3K ameliorated expression of the osteogenic markers alkaline phosphatase, type I collagen, osteopontin, and BMP-2. Expression of dominant-negative PI3K and PTEN, an inhibitor of PI3K signaling, significantly attenuated lovastatin-induced transcription of BMP-2. Akt kinase in of an activity to Inhibition of PI3K activity in to the of We of the that lovastatin stimulates of and PI3K in the in Akt and to expression osteoblast Lovastatin promotes osteoblast differentiation by increasing bone morphogenetic protein-2 (BMP-2) expression. We demonstrate that lovastatin stimulates tyrosine phosphorylation of the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), leading to an increase in its kinase activity in osteoblast cells. Inhibition of PI3K ameliorated expression of the osteogenic markers alkaline phosphatase, type I collagen, osteopontin, and BMP-2. Expression of dominant-negative PI3K and PTEN, an inhibitor of PI3K signaling, significantly attenuated lovastatin-induced transcription of BMP-2. Akt kinase in of an activity to Inhibition of PI3K activity in to the of We of the that lovastatin stimulates of and PI3K in the in Akt and to expression osteoblast by the to to activity and to osteoblast differentiation in and bone in of in increasing bone in and in in to of and the bone morphogenetic protein-2 (BMP-2) bone morphogenetic phosphatidylinositol bone morphogenetic phosphatidylinositol activity and bone in of bone to to the in bone of the of BMP-2. differentiation of by an increase in expression of alkaline phosphatase, type I collagen, bone and the expression of to by in the an that lovastatin expression osteogenic differentiation of bone demonstrate in osteoblast that lovastatin stimulates osteoblast differentiation by phosphatidylinositol 3-kinase We of to in of by the PI3K and and and the p85 and of and and and and and and the dominant-negative p85 subunit of PI3K Akt and and and Akt expression the subunit of PI3K and by and of of of and the expression in by the of and to the by and by in by the and lovastatin in the of of by and of of by and to type I collagen, osteopontin, and and to of lovastatin in the of by and and and in and and to alkaline activity and in the by of of the expression activity of and in and in the and an of the of by by of to by the phosphatidylinositol in the of and kinase Akt kinase and to the by the to and the by by of the by of by PI3K osteoblast differentiation of of in the of an of and bone in We the of PI3K in osteoblast differentiation the of lovastatin-induced bone the of PI3K in to lovastatin in cells. PI3K activity in the Lovastatin significantly PI3K activity in the in PI3K activity in the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to Lovastatin the tyrosine phosphorylation of the p85 subunit of PI3K in lovastatin stimulates the tyrosine phosphorylation of the p85 regulatory subunit of in its to increase the of PI3K in the PI3K inhibitor lovastatin-induced PI3K activity to expression. Lovastatin the expression of Inhibition of the kinase by the lovastatin-induced expression of and the that PI3K the expression of in to the that the lovastatin-induced expression of in the PI3K PI3K activity in lovastatin in the of lovastatin-induced PI3K activity in osteoblast of PI3K activity by lovastatin in the PI3K that lovastatin-induced osteoblast differentiation the expression of lovastatin osteoblast differentiation of the expression of the osteoblast alkaline in the of the lovastatin in the of and the activity of alkaline by by in lovastatin-induced expression and activity of alkaline and that the of lovastatin osteoblast differentiation expression. the of PI3K in lovastatin-induced osteoblast the of the PI3K inhibitor the lovastatin-induced expression of osteoblast differentiation markers in cells. of lovastatin-induced alkaline activity We the expression of markers of osteoblast type I and of by lovastatin of the lovastatin-induced expression of type I and and that PI3K the expression of the osteoblast of PI3K expression of to to the and alkaline and lovastatin alkaline activity of the lovastatin to lovastatin activity in the of lovastatin lovastatin to the expression of type I and by in the to demonstrate and in the of PI3K in the the of the lovastatin activity in the lovastatin and activity in the of PI3K in the activity of the by increasing of the PI3K inhibitor by lovastatin that and by and the of the p85 regulatory subunit of PI3K that kinase to lovastatin expression of PI3K in lovastatin-induced of transcription of expression of to an the subunit of expression of PI3K the lovastatin-induced transcription PI3K by the PTEN, to the of the of significantly lovastatin-induced activity demonstrate that the PI3K activity in transcription by PI3K and to of lovastatin activity of of the to lovastatin in the and the of to lovastatin in the of the p85 regulatory subunit of PI3K that activity to the activity in the and an of of the of p85 to lovastatin of the in the of the Akt in the of PI3K in Akt kinase kinase Lovastatin Akt kinase activity the of lovastatin-induced expression of in the of the to lovastatin and the phosphorylation of Akt of its to lovastatin-induced Akt phosphorylation that in of the in to Akt PI3K signaling, the PI3K inhibitor to lovastatin-induced Akt kinase activity and that Akt the of Akt in lovastatin-induced of Akt kinase and that Akt kinase lovastatin-induced activity the of an of expression of Akt the lovastatin-induced of the that Akt kinase to transcription of the in to lovastatin-induced lovastatin the of of by kinase in the of the of the to lovastatin in the to and Akt kinase activity the Akt expression by lovastatin activity in an of of Akt by lovastatin activity in of the in of expression in to lovastatin by PI3K and demonstrate of the kinase in of transcription by Akt kinase the of in expression. of in in We the of activity in cells. kinase activity in to lovastatin and and the of the lovastatin and the phosphorylation of the of in in cells. expression of lovastatin-induced transcription of expression in to expression by lovastatin the of by kinase in the of the of and the of the by lovastatin activity in the of the the PI3K and of PI3K in the PI3K inhibitor by lovastatin of phosphorylation of to PI3K expression of lovastatin-induced of that PI3K to activity in to lovastatin in lovastatin-induced lovastatin the by of of by lovastatin the of by and expression by lovastatin activity in the in the to the and the of the p85 subunit of by lovastatin activity in the in the to and the of the lovastatin activity in of the transcription phosphorylation of the of by its the of by the of the of PI3K in the of an expression the to the and the of the Lovastatin the expression of the of significantly lovastatin-induced transcription of p85 subunit of PI3K in the expression of PI3K lovastatin-induced transcription demonstrate that PI3K in to of by of the We the of lovastatin the of in cells. to in the the of in cells. Lovastatin of in kinase to the to of the the of the the of in cells. Lovastatin the of to the in that lovastatin stimulates of lovastatin-induced expression. lovastatin the of of and the of in of to lovastatin the the of the by lovastatin in the in the to and and by lovastatin and an of of by lovastatin activity in the in of the lovastatin by activity in the of the lovastatin and the expression of and in the the of in lovastatin-induced the inhibitor to activity of activity in the expression of in lovastatin-induced phosphorylation of We that transcription lovastatin-induced the of transcription an to lovastatin-induced transcription of demonstrate that the of in expression in to the of in lovastatin-induced an of the of expression and the of in lovastatin-induced by that the the significantly lovastatin-induced transcription that an in transcription of the in to that PI3K and and and and of in PI3K We the of in PI3K in to of PI3K activity that PI3K by the of to PI3K in in to of lovastatin the subunit of by Lovastatin the of PI3K activity in Lovastatin significantly PI3K activity in demonstrate that lovastatin and PI3K and that PI3K Akt of the of in its in to activity in the lovastatin-induced Akt kinase activity expression of attenuated phosphorylation of demonstrate that to Akt in to lovastatin in osteoblast lovastatin-induced PI3K and Akt in and by lovastatin and PI3K activity in the of in the to the of lovastatin the subunit of PI3K and lovastatin PI3K activity in the of in the to the of by lovastatin and Akt kinase activity in the in the to the of the of the and and by lovastatin and to the by expression and osteoblast We transcription an in the by We that lovastatin PI3K activity in the of and the tyrosine phosphorylation of the p85 subunit by and the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to lovastatin that the of PI3K by lovastatin tyrosine that the lovastatin-induced PI3K that PI3K in to of to bone expression of alkaline phosphatase, type I collagen, and demonstrate that PI3K the expression of in to lovastatin and the of the of the kinase in lovastatin-induced expression. osteogenic significantly in bone that lovastatin-induced alkaline expression and lovastatin to increase transcription in the that transcription of PI3K of PI3K the to the of Akt in its to the phosphorylation by Akt by the in its Akt to by the of Akt to the promotes and in of to of We that lovastatin the of Akt in in and by expression of Akt demonstrate of transcription by Akt kinase transcription the transcription to expression in Akt and in the phosphorylation of leading to its and to the of in transcription to the of of transcription by Akt the expression of in of significantly lovastatin-induced transcription of the expression of PI3K by an significantly transcription in to lovastatin the of that significantly lovastatin-induced transcription of to Akt We and that PI3K activity by and the of Akt to the of of phosphorylation by and demonstrate that and regulatory of PI3K activity in of the transcription and demonstrate the the of PI3K and in in the of PI3K and an in the of of in the of PI3K the subunit of in an increase in its activity to increase PI3K activity in the the the and of in to lovastatin and of We that transcription and that and that We of lovastatin-induced transcription of by by that the of transcription by lovastatin of PI3K activity by of the kinase in that lovastatin of in its activity and Akt kinase kinase activity and of in in to in to the that and PI3K activity in the that PI3K expression of BMP-2. We that PI3K to lovastatin-induced of Akt expression. the of the of by in and leading to its that the of to PI3K the in the in osteoblast by the to to activity and to osteoblast differentiation in and bone in of in increasing bone in and in in to of and the bone morphogenetic protein-2 (BMP-2) bone morphogenetic phosphatidylinositol bone morphogenetic phosphatidylinositol activity and bone in of bone to to the in bone of the of BMP-2. differentiation of by an increase in expression of alkaline phosphatase, type I collagen, bone and the expression of to by in the an that lovastatin expression osteogenic differentiation of bone demonstrate in osteoblast that lovastatin stimulates osteoblast differentiation by phosphatidylinositol 3-kinase We of to in of by the PI3K and and and the p85 and of and and and and and and the dominant-negative p85 subunit of PI3K Akt and and and Akt expression the subunit of PI3K and by and of of of and the expression in by the of and to the by and by in by the and lovastatin in the of of by and of of by and to type I collagen, osteopontin, and and to of lovastatin in the of by and and and in and and to alkaline activity and in the by of of the expression activity of and in and in the and an of the of by by of to by the phosphatidylinositol in the of and kinase Akt kinase and to the by the to and the by by of the by of by and and the p85 and of and and and and and and the dominant-negative p85 subunit of PI3K Akt and and and Akt expression the subunit of PI3K and by and of of of and the expression in by the of and to the by and by in by the and lovastatin in the of of by and of of by and to type I collagen, osteopontin, and and to of lovastatin in the of by and and and in and and to alkaline activity and in the by of of the expression activity of and in and in the and an of the of by by of to by PI3K the phosphatidylinositol in the of Akt and kinase Akt kinase and to the by the to and the by by of the by of by PI3K osteoblast differentiation of of in the of an of and bone in We the of PI3K in osteoblast differentiation the of lovastatin-induced bone the of PI3K in to lovastatin in cells. PI3K activity in the Lovastatin significantly PI3K activity in the in PI3K activity in the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to Lovastatin the tyrosine phosphorylation of the p85 subunit of PI3K in lovastatin stimulates the tyrosine phosphorylation of the p85 regulatory subunit of in its to increase the of PI3K in the PI3K inhibitor lovastatin-induced PI3K activity to expression. Lovastatin the expression of Inhibition of the kinase by the lovastatin-induced expression of and the that PI3K the expression of in to the that the lovastatin-induced expression of in the PI3K PI3K activity in lovastatin in the of lovastatin-induced PI3K activity in osteoblast of PI3K activity by lovastatin in the PI3K that lovastatin-induced osteoblast differentiation the expression of lovastatin osteoblast differentiation of the expression of the osteoblast alkaline in the of the lovastatin in the of and the activity of alkaline by by in lovastatin-induced expression and activity of alkaline and that the of lovastatin osteoblast differentiation expression. the of PI3K in lovastatin-induced osteoblast the of the PI3K inhibitor the lovastatin-induced expression of osteoblast differentiation markers in cells. of lovastatin-induced alkaline activity We the expression of markers of osteoblast type I and of by lovastatin of the lovastatin-induced expression of type I and and that PI3K the expression of the osteoblast and in the of PI3K in the the of the lovastatin activity in the lovastatin and activity in the of PI3K in the activity of the by increasing of the PI3K inhibitor by lovastatin that and by and the of the p85 regulatory subunit of PI3K that kinase to lovastatin expression of PI3K in lovastatin-induced of transcription of expression of to an the subunit of expression of PI3K the lovastatin-induced transcription PI3K by the PTEN, to the of the of significantly lovastatin-induced activity demonstrate that the PI3K activity in transcription by PI3K and to of lovastatin activity of of the to lovastatin in the and the of to lovastatin in the of the p85 regulatory subunit of PI3K that activity to the activity in the and an of of the of p85 to lovastatin of the in the of the Akt in the of PI3K in Akt kinase kinase Lovastatin Akt kinase activity the of lovastatin-induced expression of in the of the to lovastatin and the phosphorylation of Akt of its to lovastatin-induced Akt phosphorylation that in of the in to Akt PI3K signaling, the PI3K inhibitor to lovastatin-induced Akt kinase activity and that Akt the of Akt in lovastatin-induced of Akt kinase and that Akt kinase lovastatin-induced activity the of an of expression of Akt the lovastatin-induced of the that Akt kinase to transcription of the in to lovastatin-induced lovastatin the of of by kinase in the of the of the to lovastatin in the to and Akt kinase activity the Akt expression by lovastatin activity in an of of Akt by lovastatin activity in of the in of expression in to lovastatin by PI3K and demonstrate of the kinase in of transcription by Akt kinase the of in expression. of in in We the of activity in cells. kinase activity in to lovastatin and and the of the lovastatin and the phosphorylation of the of in in cells. expression of lovastatin-induced transcription of expression in to expression by lovastatin the of by kinase in the of the of and the of the by lovastatin activity in the of the the PI3K and of PI3K in the PI3K inhibitor by lovastatin of phosphorylation of to PI3K expression of lovastatin-induced of that PI3K to activity in to lovastatin in lovastatin-induced lovastatin the by of of by lovastatin the of by and expression by lovastatin activity in the in the to the and the of the p85 subunit of by lovastatin activity in the in the to and the of the lovastatin activity in of the transcription phosphorylation of the of by its the of by the of the of PI3K in the of an expression the to the and the of the Lovastatin the expression of the of significantly lovastatin-induced transcription of p85 subunit of PI3K in the expression of PI3K lovastatin-induced transcription demonstrate that PI3K in to of by of the We the of lovastatin the of in cells. to in the the of in cells. Lovastatin of in kinase to the to of the the of the the of in cells. Lovastatin the of to the in that lovastatin stimulates of lovastatin-induced expression. lovastatin the of of and the of in of to lovastatin the the of the by lovastatin in the in the to and and by lovastatin and an of of by lovastatin activity in the in of the lovastatin by activity in the of the lovastatin and the expression of and in the the of in lovastatin-induced the inhibitor to activity of activity in the expression of in lovastatin-induced phosphorylation of We that transcription lovastatin-induced the of transcription an to lovastatin-induced transcription of demonstrate that the of in expression in to the of in lovastatin-induced an of the of expression and the of in lovastatin-induced by that the the significantly lovastatin-induced transcription that an in transcription of the in to that PI3K and and and and of in PI3K We the of in PI3K in to of PI3K activity that PI3K by the of to PI3K in in to of lovastatin the subunit of by Lovastatin the of PI3K activity in Lovastatin significantly PI3K activity in demonstrate that lovastatin and PI3K and that PI3K Akt of the of in its in to activity in the lovastatin-induced Akt kinase activity expression of attenuated phosphorylation of demonstrate that to Akt in to lovastatin in osteoblast lovastatin-induced PI3K and Akt in and by lovastatin and PI3K activity in the of in the to the of lovastatin the subunit of PI3K and lovastatin PI3K activity in the of in the to the of by lovastatin and Akt kinase activity in the in the to the of the of the and and by lovastatin and PI3K osteoblast differentiation of of in the of an of and bone in We the of PI3K in osteoblast differentiation the of lovastatin-induced bone the of PI3K in to lovastatin in cells. PI3K activity in the Lovastatin significantly PI3K activity in the in PI3K activity in the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to Lovastatin the tyrosine phosphorylation of the p85 subunit of PI3K in lovastatin stimulates the tyrosine phosphorylation of the p85 regulatory subunit of in its Lovastatin to increase the of PI3K in the PI3K inhibitor lovastatin-induced PI3K activity to expression. Lovastatin the expression of Inhibition of the kinase by the lovastatin-induced expression of and the that PI3K the expression of in to the that the lovastatin-induced expression of in the PI3K PI3K activity in lovastatin in the of lovastatin-induced PI3K activity in osteoblast of PI3K activity by lovastatin in the PI3K that lovastatin-induced osteoblast differentiation the expression of lovastatin osteoblast differentiation of the expression of the osteoblast alkaline in the of the lovastatin in the of and the activity of alkaline by by in lovastatin-induced expression and activity of alkaline and that the of lovastatin osteoblast differentiation expression. the of PI3K in lovastatin-induced osteoblast the of the PI3K inhibitor the lovastatin-induced expression of osteoblast differentiation markers in cells. of lovastatin-induced alkaline activity We the expression of markers of osteoblast type I and of by lovastatin of the lovastatin-induced expression of type I and and that PI3K the expression of the osteoblast Lovastatin and in the of PI3K in the the of the lovastatin activity in the lovastatin and activity in the of PI3K in the activity of the by increasing of the PI3K inhibitor by lovastatin that and by and the of the p85 regulatory subunit of PI3K that kinase to lovastatin expression of PI3K in lovastatin-induced of transcription of expression of to an the subunit of expression of PI3K the lovastatin-induced transcription PI3K by the PTEN, to the of the of significantly lovastatin-induced activity demonstrate that the PI3K activity in Lovastatin Akt in the of PI3K in Akt kinase kinase Lovastatin Akt kinase activity the of lovastatin-induced expression of in the of the to lovastatin and the phosphorylation of Akt of its to lovastatin-induced Akt phosphorylation that in of the in to Akt PI3K signaling, the PI3K inhibitor to lovastatin-induced Akt kinase activity and that Akt the of Akt in lovastatin-induced of Akt kinase and that Akt kinase lovastatin-induced activity the of an of expression of Akt the lovastatin-induced of the that Akt kinase to transcription of the in to Lovastatin in of expression in to lovastatin by PI3K and demonstrate of the kinase in of transcription by Akt kinase the of in expression. of in in We the of activity in cells. kinase activity in to lovastatin and and the of the lovastatin and the phosphorylation of the of in in cells. expression of lovastatin-induced transcription of expression in to Lovastatin the PI3K and of PI3K in the PI3K inhibitor by lovastatin of phosphorylation of to PI3K expression of lovastatin-induced of that PI3K to activity in to lovastatin in activity in of the transcription phosphorylation of the of by its the of by the of the of PI3K in the of an expression the to the and the of the Lovastatin the expression of the of significantly lovastatin-induced transcription of p85 subunit of PI3K in the expression of PI3K lovastatin-induced transcription demonstrate that PI3K in to Lovastatin of by of the We the of lovastatin the of in cells. to in the the of in cells. Lovastatin of in kinase to the to of the the of the the of in cells. Lovastatin the of to the in that lovastatin stimulates the of in lovastatin-induced the inhibitor to activity of activity in the expression of in lovastatin-induced phosphorylation of We that transcription lovastatin-induced the of transcription an to lovastatin-induced transcription of demonstrate that the of in expression in to the of in lovastatin-induced an of the of expression and the of in lovastatin-induced by that the the significantly lovastatin-induced transcription that an in transcription of the in to that PI3K and and and and of in PI3K We the of in PI3K in to of PI3K activity that PI3K by the of to PI3K in in to of lovastatin the subunit of by Lovastatin the of PI3K activity in Lovastatin significantly PI3K activity in demonstrate that lovastatin and PI3K and that PI3K Akt of the of in its in to activity in the lovastatin-induced Akt kinase activity expression of attenuated phosphorylation of demonstrate that to Akt in to lovastatin in osteoblast cells. to the by expression and osteoblast We transcription an in the by We that lovastatin PI3K activity in the of and the tyrosine phosphorylation of the p85 subunit by and the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to lovastatin that the of PI3K by lovastatin tyrosine that the lovastatin-induced PI3K that PI3K in to of to bone expression of alkaline phosphatase, type I collagen, and demonstrate that PI3K the expression of in to lovastatin and the of the of the kinase in lovastatin-induced expression. osteogenic significantly in bone that lovastatin-induced alkaline expression and lovastatin to increase transcription in the that transcription of PI3K of PI3K the to the of Akt in its to the phosphorylation by Akt by the in its Akt to by the of Akt to the promotes and in of to of We that lovastatin the of Akt in in and by expression of Akt demonstrate of transcription by Akt kinase transcription the transcription to expression in Akt and in the phosphorylation of leading to its and to the of in transcription to the of of transcription by Akt the expression of in of significantly lovastatin-induced transcription of the expression of PI3K by an significantly transcription in to lovastatin the of that significantly lovastatin-induced transcription of to Akt We and that PI3K activity by and the of Akt to the of of phosphorylation by and demonstrate that and regulatory of PI3K activity in of the transcription and demonstrate the the of PI3K and in in the of PI3K and an in the of of in the of PI3K the subunit of in an increase in its activity to increase PI3K activity in the the the and of in to lovastatin and of We that transcription and that and that We of lovastatin-induced transcription of by by that the of transcription by lovastatin of PI3K activity by of the kinase in that lovastatin of in its activity and Akt kinase kinase activity and of in in to in to the that and PI3K activity in the that PI3K expression of BMP-2. We that PI3K to lovastatin-induced of Akt expression. the of the of by in and leading to its that the of to PI3K the in to the by expression and osteoblast We transcription an in the by We that lovastatin PI3K activity in the of and the tyrosine phosphorylation of the p85 subunit by and the tyrosine phosphorylation of the p85 regulatory subunit of PI3K in to lovastatin that the of PI3K by lovastatin tyrosine that the lovastatin-induced PI3K that PI3K in to of to bone expression of alkaline phosphatase, type I collagen, and demonstrate that PI3K the expression of in to lovastatin and the of the of the kinase in lovastatin-induced expression. osteogenic significantly in bone that lovastatin-induced alkaline expression and lovastatin to increase transcription in the that transcription of PI3K of PI3K the to the of Akt in its to the phosphorylation by Akt by the in its Akt to by the of Akt to the promotes and in of to of We that lovastatin the of Akt in in and by expression of Akt demonstrate of transcription by Akt kinase transcription the transcription to expression in Akt and in the phosphorylation of leading to its and to the of in transcription to the of of transcription by Akt the expression of in of significantly lovastatin-induced transcription of the expression of PI3K by an significantly transcription in to lovastatin the of that significantly lovastatin-induced transcription of to Akt We and that PI3K activity by and the of Akt to the of of phosphorylation by and demonstrate that and regulatory of PI3K activity in of the transcription and demonstrate the the of PI3K and in in the of PI3K and an in the of of in the of PI3K the subunit of in an increase in its activity to increase PI3K activity in the the the and of in to lovastatin and of We that transcription and that and that We of lovastatin-induced transcription of by by that the of transcription by lovastatin of PI3K activity by of the kinase in that lovastatin of in its activity and Akt kinase kinase activity and of in in to in to the that and PI3K activity in the that PI3K expression of BMP-2. We that PI3K to lovastatin-induced of Akt expression. the of the of by in and leading to its that the of to PI3K the in We and the and and of of the

References

45